New Zealand
Incannex begins Phase II trial of combination drug for rheumatoid arthritis
The trial will assess IHL-675A against the respective component APIs, CBD and HCQ, and a placebo.
New Zealand MEDSAFE grants approval for Invex’s IIH therapy trial
Cancer Society New Zealand to commence trial of oncology drug
Alterity initiates Phase II multiple system atrophy therapy trial
Pardes reports interim data from Phase I trial of oral Covid-19 antiviral
Sciwind commences dosing in Phase IIb obesity drug trial
Valneva commences Phase III trial of Covid-19 vaccine in New Zealand
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
